Dolby Laboratories Stock Today

DLB Stock  USD 73.32  0.68  0.94%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Tiny

 
High
 
Low
Dolby Laboratories is trading at 73.32 as of the 8th of September 2025, a 0.94 percent up since the beginning of the trading day. The stock's open price was 72.64. Dolby Laboratories has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on August 13, 2025, Representative Lisa McClain of US Congress acquired under $15k worth of Dolby Laboratories's common stock.
Business Domain
Technology Hardware & Equipment
IPO Date
17th of February 2005
Category
Industrials
Classification
Information Technology
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. Dolby Laboratories, Inc. The company has 61.18 M outstanding shares of which 1.51 M shares are currently shorted by investors with about 4.06 days to cover. More on Dolby Laboratories

Moving against Dolby Stock

  0.48CLS Celestica Buyout TrendPairCorr
  0.47SANM SanminaPairCorr
  0.45LNDAF Lnea Directa AseguradoraPairCorr
  0.44APH AmphenolPairCorr
  0.43FN FabrinetPairCorr
  0.43LFUS LittelfusePairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Dolby Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOKevin Yeaman
Old NameMulti Units France - Lyxor UCITS ETF Daily Leveraged Bund
Business ConcentrationElectronic Equipment, Instruments & Components, Technology Hardware & Equipment, Information Technology, NYSE Composite, SP Midcap 400, Information Technology, Electronic Equipment, Instruments & Components, Information Technology Services, Technology (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.120.0684
Way Up
Pretty Stable
Asset Turnover0.590.4662
Significantly Up
Pretty Stable
Gross Profit Margin0.670.8873
Way Down
Slightly volatile
Total Current Liabilities504.5 M480.5 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total272.8 M259.8 M
Sufficiently Up
Slightly volatile
Total AssetsB3.6 B
Way Down
Slightly volatile
Total Current AssetsB1.4 B
Way Down
Slightly volatile
Total Cash From Operating Activities314 M376.3 M
Fairly Down
Pretty Stable
Debt Levels
Dolby Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Dolby Laboratories' financial leverage. It provides some insight into what part of Dolby Laboratories' total assets is financed by creditors.
Liquidity
Dolby Laboratories has 46.99 M in debt with debt to equity (D/E) ratio of 0.02, which may show that the company is not taking advantage of profits from borrowing. Dolby Laboratories has a current ratio of 5.16, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Dolby to invest in growth at high rates of return.

Sale Purchase Of Stock

(188.13 Million)
Dolby Laboratories (DLB) is traded on New York Stock Exchange in USA. It is located in 1275 Market Street, San Francisco, CA, United States, 94103-1410 and employs 2,080 people. Dolby Laboratories is listed under Electronic Equipment, Instruments & Components category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 6.96 B. Dolby Laboratories runs under Electronic Equipment, Instruments & Components sector within Information Technology industry. The entity has 61.18 M outstanding shares of which 1.51 M shares are currently shorted by investors with about 4.06 days to cover. Dolby Laboratories has about 482.05 M in cash with 327.25 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.4.
Check Dolby Laboratories Probability Of Bankruptcy
Ownership Allocation
Dolby Laboratories holds a total of 61.18 Million outstanding shares. The majority of Dolby Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Dolby Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Dolby Laboratories. Please pay attention to any change in the institutional holdings of Dolby Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that on August 13, 2025, Representative Lisa McClain of US Congress acquired under $15k worth of Dolby Laboratories's common stock.
Check Dolby Ownership Details

Dolby Stock Institutional Holders

InstituionRecorded OnShares
Acadian Asset Management Llc2025-03-31
1.1 M
Btim Corp2025-06-30
1.1 M
Dimensional Fund Advisors, Inc.2025-06-30
1.1 M
Snyder Capital Management Lp2025-06-30
M
Schroder Investment Management Group2025-06-30
806.9 K
Charles Schwab Investment Management Inc2025-06-30
754 K
Norges Bank2025-06-30
741 K
Northern Trust Corp2025-03-31
669.4 K
Grantham, Mayo, Van Otterloo & Co., Llc2025-06-30
667.7 K
Vanguard Group Inc2025-06-30
7.6 M
Morgan Stanley - Brokerage Accounts2025-03-31
7.1 M
View Dolby Laboratories Diagnostics

Dolby Laboratories Historical Income Statement

At present, Dolby Laboratories' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 248.1 M, whereas Total Revenue is forecasted to decline to about 860.5 M. View More Fundamentals

Dolby Stock Against Markets

Dolby Laboratories Corporate Directors

Avadis TevanianIndependent DirectorProfile
Simon SegarsIndependent DirectorProfile
David DolbyIndependent DirectorProfile
Roger SiboniIndependent DirectorProfile
When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.2
Dividend Share
1.32
Earnings Share
2.71
Revenue Per Share
14.058
Quarterly Revenue Growth
0.093
The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.